Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronic Acid vs Botox for Drug-Resistant Premature Ejaculation
NCT07236632Not yet recruiting
- Sponsor
- Benha University
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes, Hydrogel Systems
01
Overview
Randomised, open-label trial of Onabotulinumtoxina + hydrogel and hyaluronic acid sodium composite gel for injection in premature ejaculation (PE) (2 arms), sponsored by Benha University. Primary endpoint: Intravaginal Ejaculatory Latency Time at 12 months. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Onabotulinumtoxina + hydrogelhyaluronic acid sodium composite gel for injection
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT07236632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07236632.